ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Rauscher Tabs Oak Ridge Immunologists To Head Basic Research At Frederick

August 30, 1974

Komen Board Approved Defunding Planned Parenthood, Says Karen Handel

February 10, 2012

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

Triple-Negative Breast Cancer Equally Aggressive in Whites

February 25, 2011

Also in this 8-page issue: Vitamin E doesn’t prevent heart events, cancer, Women’s Health Study finds.

July 8, 2005